Miyasaka N

No ORCID on file · 5 papers in corpus · active 2012-2026
2026
The journal of obstetrics and gynaecology research ·doi:10.1111/jog.70341

Cervical large-cell neuroendocrine carcinoma (LCNEC) is a rare and highly aggressive malignancy with poor prognoses, particularly in advanced or recurrent disease. We describe a case of advanced and recurrent cervical LCNEC in which long-te…

2025
F&S reports ·doi:10.1016/j.xfre.2025.10.002

ObjectiveTo study the earliest timepoint at which serum human chorionic gonadotropin (hCG) can predict live birth after blastocyst frozen embryo transfer, and to determine the cutoff values for hCG levels on days 7-11 after frozen-thawed em…

2023
Scientific reports ·doi:10.1038/s41598-023-41780-4

The effects of body mass index (BMI) on assisted reproductive technology (ART) outcomes such as ovarian dysfunction, poor ovum quality, and endometrial dysfunction have been studied; however, many aspects remain controversial. Therefore, we…

2018
Oncotarget ·doi:10.18632/oncotarget.25613

Highly malignant tumors overexpress the minichromosome maintenance 2 (MCM2) protein in the nucleus, which is associated with advanced tumor grade, advanced stage, and poor prognosis. In this study, we showed that MCM2 is highly expressed in…

2012
Modern rheumatology ·doi:10.1007/s10165-011-0557-x

We evaluated the efficacy, pharmacokinetics, and safety of adalimumab in Japanese patients with active ankylosing spondylitis (AS) who had an inadequate response to, or who were intolerant of, treatment with ≥1 nonsteroidal anti-inflammator…